(HealthDay News) — A print and web-based decision aid helps men with their decision making about prostate cancer screening, but does not affect screening rates, according to a study published online July 29 in JAMA Internal Medicine.
Kathryn L. Taylor, Ph.D., from Georgetown University in Washington, D.C., and colleagues randomly assigned 1,893 men (45 to 70 years old) to a print-based decision aid, a web-based interactive decision aid, or usual care about prostate cancer screening. The men were interviewed at various points up to 13 months later.
The researchers found that, compared with usual care, both decision aids significantly improved prostate cancer knowledge and reduced decisional conflict. A significantly higher percentage of the print and web decision aid groups reported higher satisfaction than the usual care group (60.4% print, 52.2% web, and 45.5% usual care at one month follow-up), though this was no longer significant at 13 months. However, the three groups had similar rates of prostate cancer screening at 13 months.
“Both decision aids improved participants’ informed decision making about prostate cancer screening up to 13 months later but did not affect actual screening rates,” Taylor and colleagues conclude.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)